Dabigatran in patients with myocardial injury after non-cardiac surgery (MANAGE): an international, randomised, placebo-controlled trial
PJ Devereaux, E Duceppe, G Guyatt, V Tandon… - The Lancet, 2018 - thelancet.com
Background Myocardial injury after non-cardiac surgery (MINS) increases the risk of
cardiovascular events and deaths, which anticoagulation therapy could prevent. Dabigatran …
cardiovascular events and deaths, which anticoagulation therapy could prevent. Dabigatran …
[PDF][PDF] Dabigatran in patients with myocardial injury after non-cardiac surgery (MANAGE): an international, randomised, placebo-controlled trial
PJ Devereaux, E Duceppe, G Guyatt, V Tandon… - Lancet, 2018 - uthsc.edu
Background Myocardial injury after non-cardiac surgery (MINS) increases the risk of
cardiovascular events and deaths, which anticoagulation therapy could prevent. Dabigatran …
cardiovascular events and deaths, which anticoagulation therapy could prevent. Dabigatran …
Dabigatran in patients with myocardial injury after non-cardiac surgery (MANAGE): an international, randomised, placebo-controlled trial
MANAGE Investigators - The Lancet, 2018 - experts.umn.edu
Background: Myocardial injury after non-cardiac surgery (MINS) increases the risk of
cardiovascular events and deaths, which anticoagulation therapy could prevent. Dabigatran …
cardiovascular events and deaths, which anticoagulation therapy could prevent. Dabigatran …
[PDF][PDF] Dabigatran in patients with myocardial injury after non-cardiac surgery (MANAGE): an international, randomised, placebo-controlled trial
PJ Devereaux, E Duceppe, G Guyatt, V Tandon… - Lancet, 2018 - drive.google.com
Background Myocardial injury after non-cardiac surgery (MINS) increases the risk of
cardiovascular events and deaths, which anticoagulation therapy could prevent. Dabigatran …
cardiovascular events and deaths, which anticoagulation therapy could prevent. Dabigatran …
[PDF][PDF] Dabigatran in patients with myocardial injury after non-cardiac surgery (MANAGE): an international, randomised, placebo-controlled trial
PJ Devereaux, E Duceppe, G Guyatt, V Tandon… - Lancet, 2018 - academia.edu
Background Myocardial injury after non-cardiac surgery (MINS) increases the risk of
cardiovascular events and deaths, which anticoagulation therapy could prevent. Dabigatran …
cardiovascular events and deaths, which anticoagulation therapy could prevent. Dabigatran …
Dabigatran in patients with myocardial injury after non-cardiac surgery (MANAGE): an international, randomised, placebo-controlled trial
PJ Devereaux, E Duceppe, G Guyatt, V Tandon… - ikm.ku.dk
BACKGROUND: Myocardial injury after non-cardiac surgery (MINS) increases the risk of
cardiovascular events and deaths, which anticoagulation therapy could prevent. Dabigatran …
cardiovascular events and deaths, which anticoagulation therapy could prevent. Dabigatran …
Erratum: Dabigatran in patients with myocardial injury after non-cardiac surgery (MANAGE): an international, randomised, placebo-controlled trial (The Lancet (2018) …
PJ Devereaux, E Duceppe, G Guyatt, C Kearon… - The Lancet, 2018 - elibrary.ru
Erratum: Dabigatran in patients with myocardial injury after non-cardiac surgery (MANAGE):
an international, randomised, placebo-controlled trial (The Lancet (2018) 391(10137) (2325–2334) …
an international, randomised, placebo-controlled trial (The Lancet (2018) 391(10137) (2325–2334) …
Dabigatran in patients with myocardial injury after non-cardiac surgery (MANAGE): an international, randomised, placebo-controlled trial
PJ Devereaux, E Duceppe, GH Guyatt, V Tandon… - The Lancet, 2018 - ruj.uj.edu.pl
Dabigatran in patients with myocardial injury after non-cardiac surgery (MANAGE) : an
international, randomised, placebo-controlled trial Przejdź do treści Pomoc A A A Zmień …
international, randomised, placebo-controlled trial Przejdź do treści Pomoc A A A Zmień …
[PDF][PDF] Dabigatran in patients with myocardial injury after non-cardiac surgery (MANAGE): an international, randomised, placebo-controlled trial
PJ Devereaux, E Duceppe, G Guyatt, V Tandon… - Lancet, 2018 - smc.org.br
Background Myocardial injury after non-cardiac surgery (MINS) increases the risk of
cardiovascular events and deaths, which anticoagulation therapy could prevent. Dabigatran …
cardiovascular events and deaths, which anticoagulation therapy could prevent. Dabigatran …
Dabigatran in patients with myocardial injury after non-cardiac surgery (MANAGE): an international, randomised, placebo-controlled trial.
PJ Devereaux, E Duceppe, G Guyatt… - Lancet (London …, 2018 - europepmc.org
BACKGROUND: Myocardial injury after non-cardiac surgery (MINS) increases the risk of
cardiovascular events and deaths, which anticoagulation therapy could prevent. Dabigatran …
cardiovascular events and deaths, which anticoagulation therapy could prevent. Dabigatran …